-
ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
-
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
-
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
-
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
-
UPDATE: Citi Downgrades ORIC Pharamceuticals (ORIC) to Neutral
-
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
-
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
-
UPDATE: Citi Upgrades ORIC Pharamceuticals (ORIC) to Buy
-
ORIC Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
ORIC Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
ORIC Pharmaceuticals Inc. (ORIC) Prices 5.04M Share Upsized Common Offering at $23/Sh
-
ORIC Pharmaceuticals Announces Pricing of Upsized Public Offering
-
ORIC Pharmaceuticals Announces Pricing of Upsized Public Offering
-
ORIC Pharmaceuticals (ORIC) Announces 4M Share Proposed Public Offering of Common Stock
-
ORIC Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
ORIC Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
-
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Citi Upgrades ORIC Pharamceuticals (ORIC) to Buy, Following Earnings
-
Citi Starts ORIC Pharamceuticals (ORIC) at Neutral
-
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
ORIC Pharmaceuticals, Inc. (ORIC) Prices 7.5M Share IPO at $16/Sh
-
ORIC Pharmaceuticals Announces Pricing of Initial Public Offering
-
ORIC Pharmaceuticals Announces Pricing of Initial Public Offering

